Tatva Chintan Pharma Chem Limited (TATVA) — Cash Flow-to-Debt Ratio
Tatva Chintan Pharma Chem Limited (TATVA) has a Cash Flow-to-Debt Ratio of 0.12x as of September 2023, meaning its operating cash flow of Rs135.54 Million could theoretically repay 0% of its total liabilities (Rs1.13 Billion) in one year. See TATVA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tatva Chintan Pharma Chem Limited Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Tatva Chintan Pharma Chem Limited across 8 annual periods. Also explore TATVA net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tatva Chintan Pharma Chem Limited (2018–2025)
Year-by-year debt coverage analysis for Tatva Chintan Pharma Chem Limited. For market capitalisation and broader financial context, see TATVA company net worth.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | Rs246.71 Million | Rs974.25 Million | ▼ -78.9% |
| 2024 | 1.20x | Rs980.44 Million | Rs816.36 Million | ▲ +944.0% |
| 2023 | 0.12x | Rs277.83 Million | Rs2.42 Billion | ▲ +4.6% |
| 2022 | 0.11x | Rs203.78 Million | Rs1.85 Billion | ▼ -32.7% |
| 2021 | 0.16x | Rs243.19 Million | Rs1.49 Billion | ▼ -15.3% |
| 2020 | 0.19x | Rs253.12 Million | Rs1.31 Billion | ▲ +182.7% |
| 2019 | 0.07x | Rs73.56 Million | Rs1.08 Billion | ▼ -44.1% |
| 2018 | 0.12x | Rs104.12 Million | Rs852.48 Million | — |